| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $1.99 (Beat by $0.52) |
| EPS GAAP Actual | $1.99 (Beat by $0.52) |
| Revenue Actual | $0.17898B |
| Revenue Surprise | Beat by $178.98M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.54 |
| EPS GAAP Estimate | $1.54 |
| Revenue Estimate | $0.160955B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 8.42 | 15.98 | 8.2616 | 8.67791 | 1 |
| Dec 2026 | 6.6 | 20.39 | 6.13367 | 7.50676 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.79 | 0.345 | 0.17898B | 30.92% | 27.28M |
| FQ2 2025 (Jun 2025) | 2.15 | 0.705 | 0.168299B | 20.85% | 16.6M |
| FQ1 2025 (Mar 2025) | 1.43 | 0.26 | 0.152238B | 15.86% | 12.34M |
| FQ4 2024 (Dec 2024) | -20.13 | -21.54603 | 0.149859B | 6.57% | -3.5M |
| FQ3 2024 (Sep 2024) | 3.8 | 2.64537 | 0.123638B | -28.34% | -16.4M |
| FQ2 2024 (Jun 2024) | 8.85 | 7.51165 | 0.133205B | -26.7% | -144.49M |
| FQ1 2024 (Mar 2024) | 7.42 | 7.42 | 0.12809B | -34.55% | 128.09M |
| FQ4 2023 (Dec 2023) | 5.62 | 5.62 | 0.14001B | -20.85% | 140.01M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.54
Consensus Revenue Estimates
0.160955B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.16B | -- | 0.16B | 0.17B | 2 |
| FQ3 2026 (Sep 2026) | 0.18B | -1.25 | 0.17B | 0.18B | 2 |
| FQ2 2026 (Jun 2026) | 0.18B | 7.38 | 0.18B | 0.18B | 2 |
| FQ1 2026 (Mar 2026) | 0.16B | 4.26 | 0.16B | 0.16B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.445 | 1.79 | 0.345 | 19.27% |
| FQ2 2025 (Jun 2025) | 1.445 | 2.15 | 0.705 | 32.79% |
| FQ1 2025 (Mar 2025) | 1.17 | 1.43 | 0.26 | 18.18% |
| FQ4 2024 (Dec 2024) | 1.41603 | -20.13 | -21.54603 | 107.03% |
| FQ3 2024 (Sep 2024) | 1.15463 | 3.8 | 2.64537 | 69.62% |
| FQ2 2024 (Jun 2024) | 1.33835 | 8.85 | 7.51165 | 84.88% |
| FQ1 2024 (Mar 2024) | 7.42 | 7.42 | 100% | |
| FQ4 2023 (Dec 2023) | 5.62 | 5.62 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.15B | $0.18B | $27.28M | 15.24% |
| FQ2 2025 (Jun 2025) | $0.15B | $0.17B | $16.6M | 9.86% |
| FQ1 2025 (Mar 2025) | $0.14B | $0.15B | $12.34M | 8.1% |
| FQ4 2024 (Dec 2024) | $0.15B | $0.15B | $-3.5M | -2.33% |
| FQ3 2024 (Sep 2024) | $0.14B | $0.12B | $-16.4M | -13.27% |
| FQ2 2024 (Jun 2024) | $0.28B | $0.13B | $-144.49M | -108.47% |
| FQ1 2024 (Mar 2024) | $0B | $0.13B | $128.09M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.14B | $140.01M | 100% |